Filing Details

Accession Number:
0001567619-20-016845
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-17 18:30:08
Reporting Period:
2020-09-15
Accepted Time:
2020-09-17 18:30:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611193 W Jeffrey Jacobs C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 200
Fremont CA 94555
Svp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-09-15 40,804 $5.53 106,811 No 4 S Direct
Common Stock Disposition 2020-09-16 10,000 $6.05 96,811 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
  2. This transaction was executed in multiple trades in prices ranging from $5.30 to $5.86, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. Includes 2,049 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2020.
  4. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2020.